Clinical Trial Update: Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure? [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating spironolactone for cardiovascular disease in patients with mild chronic kidney disease, focusing on safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Chronic Kidney Disease, Cardiovascular Disease | Phase 2 | Status: COMPLETED